Characterizing Clinical and Pharmacological Neuroimaging Biomarkers
NCT03842800
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
143
Enrollment
OTHER
Sponsor class
Conditions
Cognitive Impairment
Interventions
OTHER:
MRI
DRUG:
Ketamine
Sponsor
Yale University